Literature DB >> 10640851

Simultaneous reactivation of herpes simplex virus and varicella-zoster virus in a patient with idiopathic thrombocytopenic purpura.

A F Nikkels1, P Frère, L Rakic, M Fassotte, B Evrard, P De Mol, G E Piérard.   

Abstract

Simultaneous reactivation of distinct Herpesviridae with development of clinical manifestations is exceptional. We report a 48-year-old woman suffering from idiopathic thrombocytopenic purpura. As the disease remained refractory to corticosteroids, immunoglobulins and splenectomy, a cure of vinblastine was administered. An atypical stomatitis developed few days later. Immunohistochemistry on a Tzanck smear and a biopsy evidenced a Herpes simplex virus type 1 (HSV-1) infection. The patient presented simultaneously a single necrotic lesion on the abdomen. Immunohistochemistry on a skin biopsy revealed the presence of the varicella-zoster virus (VZV) gE, gB and IE63 proteins. Intravenous aciclovir was initiated. The present case of simultaneous clinical infections by HSV-I and VZV underlines the importance of complementary viral identification testing in the event of unusual clinical presentations. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  1999        PMID: 10640851     DOI: 10.1159/000018292

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

1.  Concurrent reactivation of varicella zoster virus and herpes simplex virus in an immunocompetent child.

Authors:  Hyun-Ho Park; Mu-Hyoung Lee
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

2.  Concurrent reactivation of herpes simplex and varicella zoster viruses confirmed by the loop-mediated isothermal amplification assay.

Authors:  Tsukane Kobayashi; Akiko Yagami; Kayoko Suzuki; Tetsushi Yoshikawa; Kayoko Matsunaga
Journal:  Case Rep Dermatol       Date:  2014-01-08

3.  Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.

Authors:  Guillaume Moulis; Aurore Palmaro; Laurent Sailler; Maryse Lapeyre-Mestre
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.